{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8788159", "DateCompleted": {"Year": "1996", "Month": "12", "Day": "10"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "1572-6495", "JournalIssue": {"Volume": "674", "Issue": "2", "PubDate": {"Year": "1995", "Month": "Dec", "Day": "15"}}, "Title": "Journal of chromatography. B, Biomedical applications", "ISOAbbreviation": "J Chromatogr B Biomed Appl"}, "ArticleTitle": "Determination of schizandrin in human plasma by gas chromatography-mass spectrometry.", "Pagination": {"StartPage": "293", "EndPage": "297", "MedlinePgn": "293-7"}, "Abstract": {"AbstractText": ["Schizandrin (SZ) is one of the lignan components from Schisandra fruits. A highly sensitive and precise method for the determination of SZ in human plasma was developed involving selected-ion monitoring with gas chromatography-mass spectrometry using a fused-silica capillary column. A 0.1-ml plasma sample was used for solid-phase extraction. A good linear relationship was obtained in the concentration range studied (2.0-500 ng/ml) and the method was sufficiently accurate and precise to support clinical pharmacokinetic studies. After oral administration of SZ at a dose of 15 mg to healthy male subjects, the average value of the maximum plasma concentration of SZ was 96.1 +/- 14.1 ng/ml. The plasma concentration of this substance could be monitored for 8 h after administration."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tsumura Central Research Laboratories, Ibaraki, Japan."}], "LastName": "Ono", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Matsuzaki", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wakui", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Takeda", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ikeya", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Amagaya", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Maruno", "ForeName": "M", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "J Chromatogr B Biomed Appl", "NlmUniqueID": "9421796", "ISSNLinking": "1572-6495"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cyclooctanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "0", "NameOfSubstance": "Polycyclic Compounds"}, {"RegistryNumber": "G01BQC0879", "NameOfSubstance": "schizandrin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cyclooctanes"}, {"QualifierName": [], "DescriptorName": "Drug Stability"}, {"QualifierName": ["methods", "statistics & numerical data"], "DescriptorName": "Gas Chromatography-Mass Spectrometry"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood", "pharmacokinetics"], "DescriptorName": "Lignans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["blood", "pharmacokinetics"], "DescriptorName": "Polycyclic Compounds"}, {"QualifierName": [], "DescriptorName": "Sensitivity and Specificity"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1995", "Month": "12", "Day": "15"}, {"Year": "1995", "Month": "12", "Day": "15", "Hour": "0", "Minute": "1"}, {"Year": "1995", "Month": "12", "Day": "15", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8788159", "10.1016/0378-4347(95)00298-7", "0378434795002987"]}}]}